Eptifibatide in ESPRIT: landmark study to have huge impact on practice

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1231, 2000-01, pp. : 15-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Eptifibatide: ESPRIT results have economic significance

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 269, 2000-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Small genetic variants that have a huge impact on adverse drug reactions

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 45, Iss. 2, 2015-06 ,pp. : 136-137

John Wiley & Sons Inc

Access to resources Recommend Favorite

The impact of drug-related death on staff who have experienced it as part of their caseload: An exploratory study

By Mcauley A. Forsyth A. J.

Journal of Substance Use, Vol. 16, Iss. 1, 2011-02 ,pp. : 68-78

Radcliffe Press

Access to resources Recommend Favorite

VALIANT: landmark study shows valsartan equal to captopril in MI

Inpharma, Vol. 1, Iss. 1418, 2003-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Enoxaparin/eptifibatide vs heparin/eptifibatide: antithrombotic effects

Inpharma, Vol. 1, Iss. 1430, 2004-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite